The primary objective of the Master in Research and Preclinical Development and Clinical Drug is to provide a comprehensive interdisciplinary training on all aspects of scientific, regulatory, ethical, organizational, and promotional development of a new drug, bringing together in a single training program topics that are marginally treated or completely absent in the various degree courses of Medicine, Pharmacy, Biology, CTF, etc..

As a result, those who will successfully complete the master will be in possession of a complete training on the research and development of new drugs, not only theoretically but also practically, since the participants are already active in this field or will complete the theoretical training with a internship at a pharmaceutical company or a hospital.